Bifonazole, > = 98 %(HPLC)

Code: b3563-10mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Bifonazole is used to treat several infections such as onychomycoses, otomycoses, erythrasma, psoriasis, sebopsoriasis, seborrhoeic dermatitis and ros...


en savoir plus

Votre prix
£45.00 10MG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Bifonazole is used to treat several infections such as onychomycoses, otomycoses, erythrasma, psoriasis, sebopsoriasis, seborrhoeic dermatitis and rosacea. Bifonazole is also used as an important drug to treat melanoma.

Bifonazole is an imidazole-based anti-fungal agent with broad spectrum activity against many fungi, molds, yeast and some Gram-positive bacteria. Bifonazole inhibits ergosterol biosynthetic protein 28 and Cytochrome P450 2B4.

Features and Benefits

This compound was developed by Bayer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Other Notes

Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. B3563.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.

Packaging

10, 50 mg in glass bottle

assay≥98% (HPLC)
colorwhite to off-white
formpowder
InChI keyOCAPBUJLXMYKEJ-UHFFFAOYSA-N
InChI1S/C22H18N2/c1-3-7-18(8-4-1)19-11-13-21(14-12-19)22(24-16-15-23-17-24)20-9-5-2-6-10-20/h1-17,22H
originatorBayer
Quality Level100
SMILES stringc1ccc(cc1)C(c2ccc(cc2)-c3ccccc3)n4ccnc4
solubilityDMSO: >10 mg/mL
storage temp.room temp
Code
Description
Unité de vente
Prix annoncé
Qté
B3563-50MG
Unité:50MG
Prix annoncé: £172.00
Source:Prix annoncé
Cas Number60628-96-8
Ce produit répond aux critères suivants: